Kristina Callis-Duffin

Kristina Callis-Duffin

UNVERIFIED PROFILE

Are you Kristina Callis-Duffin?   Register this Author

Register author
Kristina Callis-Duffin

Kristina Callis-Duffin

Publications by authors named "Kristina Callis-Duffin"

Are you Kristina Callis-Duffin?   Register this Author

100Publications

3948Reads

21Profile Views

Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.

J Am Acad Dermatol 2019 Oct 1;81(4):923-930. Epub 2019 Jun 1.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.05.080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746579PMC
October 2019

Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM).

Dermatology 2018 18;234(3-4):112-119. Epub 2018 Jul 18.

Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490460DOI Listing
September 2019

Achieving Consensus on Patient-Reported Outcome Measures in Clinical Practice for Inflammatory Skin Disorders: On Behalf of International Dermatology Outcome Measures and the American Academy of Dermatology.

J Am Acad Dermatol 2019 Sep 13. Epub 2019 Sep 13.

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia, and Atlanta Veterans Administration Medical Center, Decatur, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.09.008DOI Listing
September 2019

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

J Rheumatol 2019 Aug 15;46(8):990-995. Epub 2018 Dec 15.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Division of Immunology, Stanford University, Palo Alto, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co., Indianapolis, Indiana; University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, Bath; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Sorbonne Université; Rheumatology Department, Pitié Salpêtrière Hospital, AP-HP, Paris, France; VU Medical Centre, Amsterdam, the Netherlands; Global Medical Affairs, Pfizer Inc., Montreal, Quebec; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute for Health Policy Management and Evaluation, University of Toronto; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571063PMC
August 2019

Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

J Rheumatol Suppl 2019 Jun;95:1-3

From GRAPPA (Groups for Research and Assessment of Psoriasis and Psoriatic Arthritis), Seattle, Washington; University of Utah, Salt Lake City, Utah; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Kezar Life Sciences, San Francisco, California; Duke University School of Medicine, Durham, North Carolina, USA; University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190112DOI Listing
June 2019

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2019 Jun;95:11-19

From the Rheumatology Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Swedish Medical Center/Providence-St. Joseph Health, Seattle, Washington; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Department of Medical Humanities, Amsterdam University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190118DOI Listing
June 2019

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.

J Rheumatol Suppl 2019 Jun;95:33-37

From the Duke-NUS Medical School, Singapore; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah; Kezar Life Sciences, San Francisco; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam, the Netherlands; Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190122DOI Listing
June 2019

Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.

J Am Acad Dermatol 2019 Jun 1. Epub 2019 Jun 1.

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.05.075DOI Listing
June 2019

Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis.

Dermatology 2018 17;234(5-6):157-165. Epub 2018 Aug 17.

Department of Dermatology, Keck School of Medicine of University of Southern California, Los Angeles, California,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490413DOI Listing
March 2019

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

JAMA Dermatol 2018 10;154(10):1137-1144

Department of Dermatology, Keck School of Medicine of University of Southern California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.1165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233740PMC
October 2018

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.

J Invest Dermatol 2018 09 17;138(9):1973-1981. Epub 2018 Mar 17.

Departments of Dermatology and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.03.1501DOI Listing
September 2018

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.

J Rheumatol Suppl 2018 Jun;94:17-25

From the Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Royal National Hospital for Rheumatic Diseases, Bath, UK; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; University of Oxford, Oxford, UK; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA; Department of Rheumatology, St. Vincents University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; VU Medical Centre, Amsterdam, the Netherlands; IQVIA, Duke University School of Medicine, Durham, North Carolina, USA; School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health, and Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180142DOI Listing
June 2018

GRAPPA 2017 Project Report.

J Rheumatol Suppl 2018 Jun;94:48-51

From the University of Utah, Salt Lake City, Utah; University of California at San Diego, La Jolla, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; New York University School of Medicine, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180139DOI Listing
June 2018

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2018 Jun;94:54-61

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Our Lady's Hospice and Care Services; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180141DOI Listing
June 2018

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

J Rheumatol 2017 Oct 1;44(10):1522-1528. Epub 2017 Feb 1.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, University of Utah, Salt Lake City, Utah; Quintiles, Duke University School of Medicine, Durham, North Carolina; Division of Immunology, Stanford University, Palo Alto, California; Cleveland Clinic, Cleveland, Ohio; University of Pennsylvania, Philadelphia, Pennsylvania, USA; VU Medical Centre, Amsterdam; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Royal National Hospital for Rheumatic Diseases; Royal National Hospital for Rheumatic Diseases, Bath; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals UK National Health Service (NHS) Trust, Leeds, UK; Toronto Western Hospital; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto; Ottawa Hospital Research Institute, School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.160904
Publisher Site
http://dx.doi.org/10.3899/jrheum.160904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538953PMC
October 2017

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study.

J Am Acad Dermatol 2017 Oct 2;77(4):667-674. Epub 2017 Aug 2.

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.05.033DOI Listing
October 2017

Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.

J Am Acad Dermatol 2017 10;77(4):766-768

Department of Dermatology, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.04.1134DOI Listing
October 2017

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series.

JAAD Case Rep 2017 Sep 1;3(5):432-435. Epub 2017 Sep 1.

Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2017.06.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594234PMC
September 2017

Proceedings of the GRAPPA 2016 Retreat.

J Rheumatol 2017 05;44(5):668-673

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute; Division of Dermatology, Toronto Western Hospital, University of Toronto, Ontario; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Advisory Services, QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester; New York Medical College, Valhalla; Hofstra Northwell School of Medicine, New Hyde Park, New York, New York; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cleveland Clinic, Cleveland, Ohio; University of Utah, Salt Lake City, Utah; University of Southern California, Los Angeles; University of California at San Diego, San Diego, California, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Division of Rheumatology, University of Cagliari, Cagliari, Italy, Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Federal University of Paraná, Curitiba, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170141DOI Listing
May 2017

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.

J Rheumatol 2017 05;44(5):697-700

From Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Utah, Salt Lake City, Utah; QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington; International Dermatology Outcome Measurers, West Granby, Connecticut; Cleveland Clinic, Cleveland, Ohio; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Johns Hopkins University School of Medicine; Psoriatic Arthritis Program, Johns Hopkins Arthritis Center, Baltimore, Maryland, USA; VU Medical Centre, Amsterdam, the Netherlands; University of Toronto; Krembil Research Institute; Psoriatic Disease Program, Toronto Western Hospital; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; UK National Institute for Health Research (NIHR), Leeds; Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Royal United Hospital; Royal United Hospital; Pharmacy and Pharmacology, University of Bath, UK; Newman Clinical Research Professor, St. Vincent's University Hospital and University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Internal Medicine, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605807PMC
May 2017

Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.

J Rheumatol 2017 05;44(5):701-702

From the University of Utah, Salt Lake City, Utah; New York Medical College, Valhalla; Hofstra Northwell School of Medicine, Hempstead, New York; Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; International Dermatology Outcome Measurers, West Granby, Connecticut; University of Southern California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170151DOI Listing
May 2017

GRAPPA 2016 Project Report.

J Rheumatol 2017 05;44(5):706-710

From the UK National Institute for Health Research (NIHR); Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Utah, Salt Lake City, Utah; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170153DOI Listing
May 2017

Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients.

J Dermatolog Treat 2016 6;27(1):27-30. Epub 2015 Aug 6.

e Department of Dermatology , University of Utah School of Medicine , Salt Lake City , UT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/09546634.2015.1050351DOI Listing
September 2016

International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update.

J Rheumatol 2016 05;43(5):959-60

From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160114DOI Listing
May 2016

GRAPPA 2015 Research and Education Project Reports.

J Rheumatol 2016 05;43(5):979-85

From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.160119
Publisher Site
http://dx.doi.org/10.3899/jrheum.160119DOI Listing
May 2016

Presidential Round Table: A Report from the GRAPPA Annual Meeting.

J Rheumatol 2016 05;43(5):986-9

From the University of Toronto, and the Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Department of Dermatology, Division of Specialties in Medicine, University of Geneva, Geneva, Switzerland; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; University of Utah, Salt Lake City, Utah, USA.D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Krembil Research Institute, Toronto Western Hospital; P.J. Mease, MD, Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine; W.H. Boehncke, MD, MA, Professor and Chair, Department of Dermatology, Division of Specialties in Medicine, University of Geneva; P.S. Helliwell, DM, PhD, FRCP, University of Leeds, Leeds, and Bradford Hospitals NHS Foundation Trust; K. Callis Duffin, MD, University of Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160120DOI Listing
May 2016

microRNAs in Psoriasis.

J Invest Dermatol 2016 Feb;136(2):365-371

Department of Pathology, University of Utah, Salt Lake City, Utah, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/JID.2015.409DOI Listing
February 2016

Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis.

J Am Acad Dermatol 2015 Nov;73(5):868-70

Departments of Dermatology, Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2015.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609315PMC
November 2015

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.

N Engl J Med 2015 Oct;373(14):1318-28

From the Icahn School of Medicine at Mount Sinai, New York (M.L., L.K.); University of Connecticut School of Medicine, Farmington (B.S.); Probity Medical Research (B.S., L.S., D.T.) and XLR8 Medical Research (D.T.), Windsor, ON, K Papp Medical Research (K.P.), Waterloo, ON, and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Baylor University Medical Center, Dallas (A.M.); Northwestern University, Feinberg School of Medicine, Chicago (K.G.); Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) - both in Poland; Hospital de la Santa Creu i Sant Pau, Barcelona (L.P.); Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.); Florida Academic Dermatology Center, Miami (F.K.); University of Colorado, Denver (A.W.A.); Medizinische Universität Wien, Vienna, Austria (G.S.); Massachusetts General Hospital and Harvard Medical School, Boston (A.B.K.); Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint Louis, Paris (H.B.), Paul Sabatier University, Toulouse (C.P.), and University Hospital of Nice, Nice (J.-P.L.) - all in France; Kaiser Permanente Los Angeles Medical Center, Los Angeles (J.J.W.), Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield (J.C.), University of California, San Francisco, San Francisco (J.K.), and Amgen, Thousand Oaks (G.A., J.L., W.S., C.E.M., Y.S., N.E., P.K., B.K., A.N.) - all in California.; University of Texas Health Science Center, Houston (S.T.); DermResearch, Louisville, KY (L.K.); University of Rome Tor Vergata, Rome (S.C.); University of Utah Medical Center, Salt Lake City (K.C.D.); and the Psoriasis Treatment Center of Central New Jersey, East Windsor (J.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1503824DOI Listing
October 2015

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.

N Engl J Med 2015 Jul;373(2):136-44

From the Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago (K.B.G.); the Department of Dermatology, University of Utah School of Medicine, Salt Lake City (K.C.D.); Innovaderm Research, Montreal (R.B.); the Department of Dermatology, Ludwig-Maximilians-Universität München, Munich (J.C.P.), and the Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany; and Janssen Research and Development, Spring House (Y.W., S.L., Y.-K.S., P.S., B.R.), and the Department of Dermatology, University of Pennsylvania, Philadelphia (B.R.) - both in Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501646DOI Listing
July 2015

Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility.

Nat Commun 2015 Apr 23;6:6916. Epub 2015 Apr 23.

1] State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology, Anhui Medical University, Hefei, Anhui 230032, China [2] Key Lab of Dermatology (Anhui Medical University), Ministry of Education, Hefei, Anhui 230032, China [3] Collaborative Innovation Center for Complex and Severe Skin Diseases, Anhui Medical University, Hefei, Anhui 230032, China [4] Department of Human Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore [5] Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore, 138672, Singapore [6] School of Life Sciences, Anhui Medical University, Hefei, Anhui 230032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423213PMC
April 2015

Identifying and Managing Complications and Comorbidities in Patients With Psoriasis.

Semin Cutan Med Surg 2015 Mar;34(2 Suppl):S30-3

University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/j.sder.2015.0135DOI Listing
March 2015

Screening and Monitoring Before and During Systemic Therapy: Recommendations for Patients With Psoriasis.

Semin Cutan Med Surg 2015 Mar;34(2 Suppl):S40-2

University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/j.sder.2015.0138DOI Listing
March 2015

The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.

J Am Acad Dermatol 2015 Feb 6;72(2):345-8. Epub 2014 Dec 6.

Department of Rheumatology, Michigan State University, Parker Institute, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.11.002DOI Listing
February 2015

Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.

J Am Acad Dermatol 2014 Dec 24;71(6):1167-75. Epub 2014 Sep 24.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.08.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271825PMC
December 2014

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.

J Am Acad Dermatol 2014 Oct 2;71(4):623-32. Epub 2014 Jun 2.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.04.063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165651PMC
October 2014

Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.

J Am Acad Dermatol 2014 Oct 11;71(4):633-41. Epub 2014 Jun 11.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165851PMC
October 2014

Work productivity loss and fatigue in psoriatic arthritis.

J Rheumatol 2014 Aug 15;41(8):1670-4. Epub 2014 Jul 15.

From the Division of Rheumatology, Division of Epidemiology, Department of Dermatology, University of Utah; Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, Utah, USA.J.A. Walsh, MD, Assistant Professor of Rheumatology, Division of Rheumatology, University of Utah, and Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center; M.L. McFadden, MS, Biostatistician III, Division of Epidemiology, University of Utah; M.D. Morgan, MD, Fellow of Rheumatology, Division of Rheumatology, University of Utah, and Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center; A.D. Sawitzke, MD, Professor of Rheumatology, Division of Rheumatology; K. Callis Duffin, MD, Assistant Professor of Dermatology; G.G. Krueger, MD, Professor of Dermatology, Department of Dermatology, University of Utah; D.O. Clegg, MD, Professor of Rheumatology, Division of Rheumatology, University of Utah, and Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140259DOI Listing
August 2014

The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting.

J Rheumatol 2014 Jun;41(6):1227-9

From the Tufts Medical Center, Boston, Massachusetts; Department of Dermatology, University of Colorado, Denver, Colorado, USA; Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark; Department of Dermatology, Hofstra North Shore LIJ School of Medicine, Hempstead, New York; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Department of Dermatology, Geneva University Hospital, Geneva, Switzerland; Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA; University of Toronto, Toronto Western Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Seattle Rheumatology Associates, Rheumatology Research, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, Emory University, Atlanta, Georgia, USA; Division of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada; National Psoriasis Foundation, Portland, Oregon, USA.A.B. Gottlieb, MD, PhD, Tufts Medical Center; A.W. Armstrong, MD, MPH, Department of Dermatology, University of Colorado; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital; A. Garg, MD, Department of Dermatology, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, MS, Department of Dermatology, University of Utah; W-H. Boehncke, MD, Department of Dermatology, Geneva University Hospital; J.F. Merola, MD, Harvard Medical School, Brigham and Women's Hospital; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Senior Scientist, Toronto Western Research Institute; Director, Psoriatic Arthritis Program, University Health Network; P.J. Mease, MD, Seattle Rheumatology Associates, Director, Rheumatology Research, Swedish Medical Center, Clinical Professor, Univ

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140176DOI Listing
June 2014

Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.

J Rheumatol 2014 Jun;41(6):1240-3

From the University of Utah, Salt Lake City, Utah; Department of Dermatology, Hofstra North Shore LIJ School of Medicine, Hempstead, New York; Department of Dermatology, University of Colorado, Denver, Colorado, USA; Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington, USA.K. Callis Duffin, MD, University of Utah; A. Garg, MD, Associate Professor, Department of Dermatology, Hofstra North Shore LIJ School of Medicine; A.W. Armstrong, MD, MPH, Department of Dermatology, University of Colorado; P.S. Helliwell, DM, PhD, Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital; P.J. Mease, MD, Rheumatology Research, Swedish Medical Center; Clinical Professor, University of Washington School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140180DOI Listing
June 2014

Practice GAPS: preventing and detecting antibodies to anti-tumor necrosis factor agents: gaps in practice or in evidence?

JAMA Dermatol 2014 Feb;150(2):136-7

Department of Dermatology, University of Utah School of Medicine, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2013.8375DOI Listing
February 2014

Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.

J Am Acad Dermatol 2013 Dec 17;69(6):931-7. Epub 2013 Sep 17.

Division of Rheumatology, University of Utah, Salt Lake City, Utah. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.07.040DOI Listing
December 2013

Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.

J Rheumatol 2013 Aug;40(8):1423-4

Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130454DOI Listing
August 2013

Dermatology screening tools: project update from the GRAPPA 2012 annual meeting.

J Rheumatol 2013 Aug;40(8):1425-7

University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130455DOI Listing
August 2013

Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting.

J Rheumatol 2013 Aug;40(8):1455-6

University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130463DOI Listing
August 2013

Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.

J Rheumatol 2013 Mar 1;40(3):287-93. Epub 2013 Feb 1.

Division of Rheumatology and the Department of Dermatology, University of Utah, Salt Lake City, UT 84109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.120836DOI Listing
March 2013

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

J Am Acad Dermatol 2013 Feb 19;68(2):262-9. Epub 2012 Aug 19.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2012.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644426PMC
February 2013

Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.

J Clin Sleep Med 2012 Dec 15;8(6):643-8. Epub 2012 Dec 15.

George E. Wahlen Veteran Affairs Medical Center, University of Utah, Division of Rheumatology, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5664/jcsm.2254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501660PMC
December 2012

Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.

J Rheumatol 2012 Nov;39(11):2198-200

University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.120823DOI Listing
November 2012

Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients.

J Am Acad Dermatol 2012 Mar 19;66(3):376-86. Epub 2011 Aug 19.

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2011.03.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223538PMC
March 2012

Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.

J Drugs Dermatol 2012 Feb;11(2):160-7

Department of Dermatology, School of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
February 2012

Psoriasis and psoriatic arthritis video project: an update from the 2010 GRAPPA annual meeting.

J Rheumatol 2012 Feb;39(2):421-2

University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.111239DOI Listing
February 2012

Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.

J Rheumatol 2011 Mar;38(3):562-3

University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.101122DOI Listing
March 2011

Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association.

Dermatol Ther 2010 Mar-Apr;23(2):101-13

4A330 School of Medicine, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1529-8019.2010.01303.xDOI Listing
July 2010

Obesity in early adulthood as a risk factor for psoriatic arthritis.

Arch Dermatol 2010 Jul;146(7):721-6

Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archdermatol.2010.141DOI Listing
July 2010

Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.

Am J Med Sci 2010 Jun;339(6):580-1

Department of Internal Medicine, University of Utah, Salt Lake City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0b013e3181dd1aa5DOI Listing
June 2010

Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.

J Invest Dermatol 2009 Dec 25;129(12):2777-83. Epub 2009 Jun 25.

Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1534162
Publisher Site
http://dx.doi.org/10.1038/jid.2009.169DOI Listing
December 2009

Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association.

J Invest Dermatol 2009 Apr 2;129(4):827-33. Epub 2008 Oct 2.

Department of Dermatology, School of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah 84132-2409, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2008.308DOI Listing
April 2009

Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis.

J Am Acad Dermatol 2009 Apr 24;60(4):604-8. Epub 2009 Jan 24.

Department of Dermatology, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2008.10.059DOI Listing
April 2009

Psoriasis bench to bedside: genetics meets immunology.

Arch Dermatol 2009 Apr;145(4):462-4

University of Michigan, Department of Dermatology, 3312 CCGC, Box 0932, Ann Arbor, MI 48109-0932, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archdermatol.2009.73DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739283PMC
April 2009

Androgen receptor expression patterns in Becker's nevi: an immunohistochemical study.

J Am Acad Dermatol 2008 Nov;59(5):834-8

Department of Dermatology, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2008.06.028DOI Listing
November 2008

Onychodystrophy and tumor-stage mycosis fungoides confined to a single digit: report of a case and review of nail findings in cutaneous T-cell lymphoma.

J Am Acad Dermatol 2008 Jul 7;59(1):154-7. Epub 2008 May 7.

Department of Dermatology, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2008.03.037DOI Listing
July 2008

Genetics of psoriasis and psoriatic arthritis: update and future direction.

J Rheumatol 2008 Jul;35(7):1449-53

Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724000PMC
July 2008